Trial of Naltrexone and Dextromethorphan for Gulf War Illness
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
Veterans of the 1991 Gulf War who developed Gulf War Illness are being studied. Treatments
with FDA approved generic drugs are being administered to see if they help with the symptoms
of Gulf War Illness, such as chronic fatigue; difficulty with memory, concentration, and
thinking; widespread chronic pain; and autonimic dysfunction. Drugs to be tested are
dextromethorphan and naltrexone.